European Medical Solutions

European Medical Solutions FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of European Medical Solutions (ALEMS.BR) as of Nov 10, 2026 is 135.54 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was -186.08 % — a change of -172.84% (higher).

FCF Conversion

135.54 %

YoY

-172.84%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of European Medical Solutions is 2025 135.54 % . FCF Conversion Rate (FCF/EBITDA) of European Medical Solutions was 2024 -186.08 % . It decreases by -172.84% higher compared to the previous year.

The European Medical Solutions FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2018
93.49 EUR
Jan 1, 2019
83.49 EUR
Jan 1, 2020
101.10 EUR
Jan 1, 2021
652.70 EUR
Jan 1, 2022
2.10 EUR
Jan 1, 2023
683.07 EUR
Jan 1, 2024
-186.08 EUR
Jan 1, 2025
135.54 EUR
The European Medical Solutions FCF Conversion history
YEARFCF ConversionYoY
135.54 %-172.84%
-186.08 %-127.24%
683.07 %+32,459.90%
2.10 %-99.68%
652.70 %+545.59%
101.10 %+21.10%
83.49 %-10.70%
93.49 %-13.77%
108.43 %-4.98%
114.11 %+6.16%
107.49 %+33.77%
80.36 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

European Medical Solutions Stock analysis

What does European Medical Solutions do? European Medical Solutions SA operates in the Health Care sector, specifically within the biotechnology industry. Headquartered in Liege, Belgium, the company is a clinical-stage biopharmaceutical entity focused on the research and development of immunotherapy treatments for environmental and food allergies. It currently employs 20 full-time staff members. The company listed its shares on the stock exchange on 11 May 2016, marking its entry into public markets while maintaining its focus on advancing novel therapeutic solutions in the allergy treatment space. European Medical Solutions is one of the most popular companies on Eulerpool.

Frequently Asked Questions about European Medical Solutions stock

FCF Conversion Rate (FCF/EBITDA) of European Medical Solutions is 135.54 % in 2025.

FCF Conversion Rate (FCF/EBITDA) of European Medical Solutions changed from -186.08 % to 135.54 %, representing a -172.84% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) European Medical Solutions since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s European Medical Solutions with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — European Medical Solutions

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — European Medical Solutions